ResMed Inc. vs Schlumberger NV — how do they compare? ResMed Inc. trades at $220 (market cap $32.61B), while Schlumberger NV trades at $53.7 (market cap $79.67B). The key difference: Schlumberger NV is far larger — about 2.4× ResMed Inc.'s market cap, and Schlumberger NV pays the higher dividend (2.2%). Which is the better fit depends on your goals.
| RMD | SLB | |
|---|---|---|
Market Cap | $32.61B | $79.67B |
Sector | Health | Energy |
52-Week High | $293.73 | $58.01 |
52-Week Low | $182.82 | $31.72 |
Enterprise Value | $31.97B | $88.40B |
Dividend Yield | 1.17% | 2.2% |
Trailing returns across standard periods
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →